Info: Read More
  • 中药标准品生产商,产品定制服务
  • 薯蓣皂甙;薯蓣皂苷


    产品编号 CFN99516
    CAS编号 19057-60-4
    分子式 = 分子量 C45H72O16 = 869.05
    产品纯度 >=98%
    物理属性 Powder
    化合物类型 Steroids
    植物来源 The rhizomes of Dioscorea Zingiberensis C.H.Wright.
    产品名称 产品编号 CAS编号 包装 QQ客服
    薯蓣皂甙;薯蓣皂苷 CFN99516 19057-60-4 10mg QQ客服:2159513211
    薯蓣皂甙;薯蓣皂苷 CFN99516 19057-60-4 20mg QQ客服:2159513211
    薯蓣皂甙;薯蓣皂苷 CFN99516 19057-60-4 50mg QQ客服:2159513211
    薯蓣皂甙;薯蓣皂苷 CFN99516 19057-60-4 100mg QQ客服:2159513211
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: 或

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.

    PMID: 30417089
  • Sanford Burnham Medical Research Institute (USA)
  • Molecular Biology Institute of Barcelona (IBMB)-CSIC (Spain)
  • Mahidol University (Thailand)
  • University of Perugia (Italy)
  • Institute of Tropical Disease Universitas Airlangga (Indonesia)
  • Monash University Malaysia (Malaysia)
  • Donald Danforth Plant Science Center (USA)
  • University of Eastern Finland (Finland)
  • National Cancer Institute (USA)
  • The Ohio State University (USA)
  • Complutense University of Madrid (Spain)
  • University of Auckland (New Zealand)
  • University of Hertfordshire (United Kingdom)
  • University of Illinois at Chicago (USA)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • J Ethnopharmacol.2017, 206:73-77
  • Phytomedicine.2019, 55:229-237
  • Medicinal Chemistry Research 2021, 30:1117-1124.
  • Acta Agriculturae Scandinavica2015, 381-383
  • Chemistry of Plant Raw Materials2022, 20220210569.
  • Life (Basel).2021, 11(12):1399.
  • Wageningen University & Research2018, January 2018
  • J Clin Med.2019, 8(10):E1664
  • J of Dentistry & Oral Health2019, 2641-1962
  • BMC Complement Altern Med.2019, 19(1):11
  • Universidade Estadual Paulista2017, 11449
  • Anal Bioanal Chem.2020, 412(12):3005-3015.
  • Journal of Ginseng Research2021, 15 June.
  • Appl. Sci.2020, 10(16),5482.
  • Appl. Sci. 2021, 11(23),11099.
  • Biofactors.2018, 44(2):168-179
  • Fitoterapia.2022, 157:105130.
  • Org Biomol Chem.2017, 15(31):6483-6492
  • Antioxidants (Basel).2020, 9(6):466.
  • Neurochem Res.2021, s11064-021-03449-0
  • BMC Plant Biol.2018, 18(1):122
  • Int J Biol Macromol.2021, 199:189-200.
  • Nutrients.2018, 10(7)
  • ...
  • 生物活性
    Description: Dioscin has anti-obesity, antineoplastic, anti-cancer, anti-inflammatory, uricosuric and nephroprotective actions, it can potentially contribute to treatments for inflammatory diseases and atherosclerosis. Dioscin clearly protected PC12 cells and primary cortical neurons against OGD/R insult and significantly prevented cerebral I/R injury. It inhibited AMPK/MAPK pathway and regulated VEGFR2 and AKT/MAPK signaling pathways.
    Targets: NF-kB | AP-1 | STAT | LTR | TNF-α | ERK | JNK | AMPK | VEGFR | Src | FAK | Akt | p38MAPK
    In vitro:
    Biochimie. 2015 Mar;110:62-72.
    Potent anti-inflammatory effect of dioscin mediated by suppression of TNF-α-induced VCAM-1, ICAM-1and EL expression via the NF-κB pathway.[Pubmed: 25577996]
    The modulation of adhesion molecule expression and the reduction of aberrant leukocyte adhesion to the endothelium are attractive approaches for treating inflammation-related vascular complications, including atherosclerosis. Dioscin has a variety of biological activities including anti-inflammatory activity. However, the molecular mechanisms behind dioscin's anti-inflammatory effects are not fully understood.
    In this study, we investigated the molecular mechanism involved in the effects of dioscin on inflammatory mediators in tumor necrosis factor-α (TNF-α)-stimulated human umbilical vein endothelial cells (HUVECs). In vitro, dioscin decreased monocyte adhesion to TNF-α-treated HUVECs by reducing vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1) expression and inhibiting endothelial lipase (EL) expression in TNF-α-treated HUVECs and macrophages by blocking the nuclear factor-κB (NF-κB) pathway.
    Thus, dioscin might inhibit inflammation by interrupting the NF-κB signaling pathway and could potentially contribute to treatments for inflammatory diseases and atherosclerosis.
    J Nat Prod. 2013 May 24;76(5):909-14.
    Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition.[Pubmed: 23621869 ]
    The purpose of this study was to investigate the ameliorating effect of dioscin (1) on multidrug resistance (MDR) in adriamycin (ADR)-resistant erythroleukemic cells (K562/adriamycin, K562/ADR) and to clarify the molecular mechanisms involved.
    High levels of multidrug resistance 1 (MDR1) mRNA and protein and reduced ADR retention were found in K562/ADR cells compared with parental cells (K562). Dioscin (1), a constituent of plants in the genus Discorea, significantly inhibited MDR1 mRNA and protein expression and MDR1 promoter and nuclear factor κ-B (NF-κB) activity in K562/ADR cells. MDR1 mRNA and protein suppression resulted in the subsequent recovery of intracellular drug accumulation. Additionally, inhibitor κB-α (IκB-α) degradation was inhibited by 1. Dioscin (1) reversed ADR-induced MDR by down-regulating MDR1 expression by a mechanism that involves the inhibition of the NF-κB signaling pathway.
    These findings provide evidence to support the further investigation of the clinical application of dioscin (1) as a chemotherapy adjuvant.
    In vivo:
    Free Radic Biol Med. 2015 Mar 12.
    Dioscin ameliorates cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via HMGB-1 inhibition.[Pubmed: 25772012]
    We previously reported the promising effect of dioscin against hepatic ischemia/reperfusion (I/R) injury, but its effect on cerebral I/R injury remains unknown.
    In this work, an in vitro oxygen-glucose deprivation and reoxygenation (OGD/R) model and an in vivo middle cerebral artery occlusion (MCAO) model were used. The results indicated that dioscin clearly protected PC12 cells and primary cortical neurons against OGD/R insult and significantly prevented cerebral I/R injury. Further research demonstrated that dioscin-induced neuroprotection was accompanied by a significant inhibition in the expression and the nuclear to cytosolic translocation of HMGB-1, reflected by decreased TLR4 expression. Blockade of the TLR4/MyD88/TRAF6 signaling pathway by dioscin inhibited NF-κB and AP-1 transcriptional activities, MAPK and STAT3 phosphorylation, and pro-inflammatory cytokine responses, and upregulated the levels of anti-inflammatory factors. In addition, small interfering RNA (siRNA) and overexpressed genes of HMGB-1 and TLR4 were applied in in vitro experiments, respectively, and the results further confirmed that dioscin showed an efficient neuroprotection because of its inhibiting effects on HMGB-1/TLR4 signaling and subsequent suppressing inflammation.
    These findings provide new insights that will aid in elucidating the effect of dioscin against cerebral I/R injury and support the development of dioscin as a potential treatment for ischemic stroke.
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 1.1507 mL 5.7534 mL 11.5068 mL 23.0136 mL 28.767 mL
    5 mM 0.2301 mL 1.1507 mL 2.3014 mL 4.6027 mL 5.7534 mL
    10 mM 0.1151 mL 0.5753 mL 1.1507 mL 2.3014 mL 2.8767 mL
    50 mM 0.023 mL 0.1151 mL 0.2301 mL 0.4603 mL 0.5753 mL
    100 mM 0.0115 mL 0.0575 mL 0.1151 mL 0.2301 mL 0.2877 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    短葶山麦冬皂苷C; Liriope muscari baily saponins C CFN90194 87480-46-4 C44H70O14 = 855.02 20mg QQ客服:215959384
    麦冬皂苷D'; Ophiopogonin D' CFN90503 65604-80-0 C44H70O16 = 855.02 10mg QQ客服:1457312923
    纤细薯蓣皂苷; Gracillin CFN98537 19083-00-2 C45H72O17 = 885.04 20mg QQ客服:2056216494
    重楼皂苷D; Polyphyllin D CFN90255 50773-41-6 C44H70O16 = 855.02 20mg QQ客服:3257982914
    薯蓣皂甙;薯蓣皂苷; Dioscin CFN99516 19057-60-4 C45H72O16 = 869.05 20mg QQ客服:2159513211
    重楼皂苷II; Polyphyllin II CFN99953 76296-72-5 C44H70O16 = 855.02 5mg QQ客服:2056216494
    重楼皂苷E; Polyphyllin E CFN90446 76296-73-6 C51H82O20 = 1015.18 5mg QQ客服:1457312923
    重楼皂苷F; Polyphyllin F CFN90447 76296-74-7 C51H82O20 = 1015.18 5mg QQ客服:215959384





    在线QQ: 1413575084


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产